EphA2 silencing in nasopharyngeal carcinoma leads to decreased proliferation, invasion and increased sensitization to paclitaxel
about
Ephrin type‑A receptor 2 regulates sensitivity to paclitaxel in nasopharyngeal carcinoma via the phosphoinositide 3‑kinase/Akt signalling pathwayIntegrated Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) and Isobaric Tags for Relative and Absolute Quantitation (iTRAQ) Quantitative Proteomic Analysis Identifies Galectin-1 as a Potential Biomarker for Predicting Sorafenib ResistRSF1 regulates the proliferation and paclitaxel resistance via modulating NF-κB signaling pathway in nasopharyngeal carcinoma.Involvement of ephrin receptor A4 in pancreatic cancer cell motility and invasion.Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry.
P2860
EphA2 silencing in nasopharyngeal carcinoma leads to decreased proliferation, invasion and increased sensitization to paclitaxel
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
EphA2 silencing in nasopharyng ...... ed sensitization to paclitaxel
@en
type
label
EphA2 silencing in nasopharyng ...... ed sensitization to paclitaxel
@en
prefLabel
EphA2 silencing in nasopharyng ...... ed sensitization to paclitaxel
@en
P2093
P2860
P356
P1433
P1476
EphA2 silencing in nasopharyng ...... ed sensitization to paclitaxel
@en
P2093
Changyun Yu
Donghai Huang
Pingqing Tan
Xiaojuan Zhou
Yongquan Tian
Yuanzheng Qiu
Zhongwu Su
P2860
P304
P356
10.3892/OL.2012.746
P577
2012-06-08T00:00:00Z